These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 10694102)

  • 1. PAS infusion in treatment of multidrug-resistant tuberculosis.
    Fodor T; Pataki G; Schrettner M
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):187-8. PubMed ID: 10694102
    [No Abstract]   [Full Text] [Related]  

  • 2. [Two cases of multi-drug-resistant pulmonary tuberculosis with para-aminosalicylic acid (PAS)-induced hypothyroidism].
    Mizutani H; Horiba M; Shindoh J; Kimura T; Son M; Wakahara K
    Kekkaku; 2001 Oct; 76(10):667-72. PubMed ID: 11712388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Para-aminosalicylic acid (PAS) desensitization review in a case of multidrug-resistant pulmonary tuberculosis.
    Wilson JW; Kelkar P; Frigas E
    Int J Tuberc Lung Dis; 2003 May; 7(5):493-7. PubMed ID: 12757053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment outcome of patients with multidrug-resistant pulmonary tuberculosis during pregnancy].
    Takashima T; Danno K; Tamura Y; Nagai T; Matsumoto T; Han Y; Ano H; Yoshida H; Kawahara K; Tsuyuguchi I
    Kekkaku; 2006 Jun; 81(6):413-8. PubMed ID: 16838679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel pediatric delivery systems for second-line anti-tuberculosis medications: a case study.
    Furin J; Brigden G; Lessem E; Becerra MC
    Int J Tuberc Lung Dis; 2013 Sep; 17(9):1239-41. PubMed ID: 23827936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.
    Park SK; Lee WC; Lee DH; Mitnick CD; Han L; Seung KJ
    Int J Tuberc Lung Dis; 2004 Mar; 8(3):361-8. PubMed ID: 15139476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trench warfare in a battle with TB.
    Marshall E
    Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790
    [No Abstract]   [Full Text] [Related]  

  • 9. A retrospective study for the outcome of pulmonary resection in 49 patients with multidrug-resistant tuberculosis.
    Park SK; Lee CM; Heu JP; Song SD
    Int J Tuberc Lung Dis; 2002 Feb; 6(2):143-9. PubMed ID: 11931413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of multidrug-resistant tuberculosis: should you try this at home?
    Griffith DE
    Am J Respir Crit Care Med; 2004 May; 169(10):1082-3. PubMed ID: 15132956
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of multidrug-resistant tuberculosis: definition of the outcome 'failure'.
    Chiang CY; Van Deun A; Trébucq A; Heldal E; Caminero JA; Aït-Khaled N
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):4-5. PubMed ID: 21276289
    [No Abstract]   [Full Text] [Related]  

  • 12. Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB.
    Chan ED; Strand MJ; Iseman MD
    Clin Infect Dis; 2009 Mar; 48(5):e50-2. PubMed ID: 19191632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis.
    Moulding T
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1102; author reply 1102. PubMed ID: 18713512
    [No Abstract]   [Full Text] [Related]  

  • 14. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Gupta R; Espinal MA; Raviglione MC
    Int J Tuberc Lung Dis; 2000 Nov; 4(11):1089-91. PubMed ID: 11092726
    [No Abstract]   [Full Text] [Related]  

  • 15. Multidrug-resistant tuberculosis.
    Carlos L; da Silva C; Müller L; da Silva C
    N Engl J Med; 1996 Jan; 334(4):267-8; author reply 268-9. PubMed ID: 8532009
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful oral desensitization to i.v. para-aminosalicylic acid (PAS) using encapsulated PAS dry substance.
    Vesenbeckh SM; Becker J; Huhnt C; Karras B; Bauer TT; Mauch H; Rüssmann H; Schönfeld N
    Infection; 2012 Apr; 40(2):199-202. PubMed ID: 21833615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria.
    Rengarajan J; Sassetti CM; Naroditskaya V; Sloutsky A; Bloom BR; Rubin EJ
    Mol Microbiol; 2004 Jul; 53(1):275-82. PubMed ID: 15225321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis.
    Garner P; Holmes A
    Clin Evid; 2002 Jun; (7):747-56. PubMed ID: 12230701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.